Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 28, 2025 09:39 ET | Source: Research and Markets

Facioscapulohumeral Muscular Dystrophy Pipeline Market Insight Report 2025 | In-depth Analysis of 10+ Companies and 12+ Pipeline Drugs

Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "Facioscapulohumeral Muscular Dystrophy - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering The "Facioscapulohumeral...
May 21, 2025 09:39 ET | Source: Research and Markets

Duchenne Muscular Dystrophy Global Clinical Trials Market Review 2025

Dublin, May 21, 2025 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2025" has been added to ResearchAndMarkets.com's offering. This clinical trial report...
May 08, 2025 04:24 ET | Source: Research and Markets

Duchenne Muscular Dystrophy (DMD) Pipeline Insight Report 2025, Featuring Analysis of Vamorolone (Santhera), Givinostat (Italfarmaco), and Pamrevlumab (Fibrogen)

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
November 29, 2024 04:29 ET | Source: Research and Markets

Limb-Girdle Muscular Dystrophy (LGMD) Competitive Landscape Report 2024

Dublin, Nov. 29, 2024 (GLOBE NEWSWIRE) -- The "Limb-Girdle Muscular Dystrophy (LGMD): Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This report provides a...
August 12, 2024 04:38 ET | Source: Research and Markets

Duchenne Muscular Dystrophy Pipeline Insight Report 2024: Emerging Therapies Shows Promising Prospects for Patients

Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.A comprehensive analysis reveals...
June 02, 2023 05:48 ET | Source: Research and Markets

Duchenne Muscular Dystrophy Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

Dublin, June 02, 2023 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries,...